Eupraxia Trial Data Shows Lasting Tissue Healing In Patients With Inflamed Esophagus

Eupraxia Pharmaceuticals reported new trial data showing EP-104GI improved esophagus tissue health and maintained remission ...

Eupraxia Pharmaceuticals Inc.: Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near ...

At week 12, the highest dosed patients achieved the best tissue response seen in the trial to date, with a near complete improvement in tissue health1- At lower doses, patients maintained the improvem ...

Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvem…

At week 12, the highest dosed patients achieved the best tissue response seen in the trial to date, with a near complete ...
Everyday Health on MSN

We asked dietitians which anti-inflammatory supplements they recommend — here’s what they said

Explore the 10 best anti-inflammatory supplements reviewed by RDs. From joint support to heart health, these expert-approved picks are worth trying in 2026.
Zacks Small Cap Research on MSN

ARWR: Encouraging early data for obesity programs

ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Encouraging Early Data for Obesity Programs On January 6, 2026, ...

Beyond Topical Treatment: Oral Thrush (Oropharyngeal Candidiasis) Explained

Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...

Combination therapy against brain cancer proves effective in preclinical models

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...